Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses

Biochemical and Biophysical Research Communications

Volumn 309, Issue 4, 2003, Pages 1017-1026

  Leonard, Stephen S ^a   Xia, Chang ^b   Jiang, Bin Hua ^b   Stinefelt, Beth ^b   Klandorf, Hillar ^b   Harris, Gabriel K ^a   Shi, Xianglin ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Cr(VI); DNA damage; Hydroxyl radicals; Lipid peroxidation; NF B activation; Resveratrol; Superoxide radicals

Indexed keywords

HYDROXYL RADICAL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; REACTIVE OXYGEN METABOLITE; RESVERATROL; SUPEROXIDE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL MEMBRANE; CELL PROTECTION; CONTROLLED STUDY; DNA DAMAGE; DRUG EFFECT; LIPID PEROXIDATION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0141788133     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.08.105     Document Type: Article

References (58)

1. Wang H., Guohua C., Prior R. Total antioxidant capacity of fruits. J. Agric. Food Chem. 44:1996;701-705.
2. Eberhardt M.V., Lee C.Y., Liu R.H. Antioxidant activity of fresh apples. Nature. 405:2000;903-904.
3. Leonard S.S., Cutler D., Ding M., Vallyathan V., Castranova V., Shi X. Antioxidant properties of fruit and vegetable juices: more to the story than ascorbic acid. Ann. Clin. Lab. Sci. 32:2002;193-200.
4. Fauconneau B., Waffo-Teguo P., Huguet F., Barrier L., Decendit A., Merillon J.M. Comparative study of radical scavenger and antioxidant properties of phenolic compounds from vitis vinifera cell culture using in vitro tests. Life Sci. 61:1997;2103-2110.
5. ′ -5-trihydroxystilbene) after short-term or prolonged administration of red wine to rats Int. J. Tissue React. 18:1996;67-71.
6. Privat C., Telo J.P., Bernardes-Genisson V., Vieira A., Souchard J.P., Nepveu F. Antioxidant properties of trans-epsilon-viniferin as compared to stilbene derivatives in aqueous and nonaqueous media. J. Agric. Food Chem. 50:2002;1213-1217.
7. Frankel E.N., Kanner J., German J.B., Parks E., Kinsella J.E. Inhibition of human low-intensity lipoprotein by phenolic substances in red wine. Lancet. 341:1993;454-457.
8. Ray P.S., Maulik G., Cordis G.A., Bertelli A.A., Bertilli A., Das D.K. The red wine antioxidant resveratrol protects isolated rat hearts from ischemia-reperfusion injury. Free Radic. Biol. Med. 27:1999;160-169.
9. Hayek T., Fuhrman B., Vaya J., Rosenblat M., Belinky P., Coleman R., Elis A., Aviram M. Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin of catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. Arterioscler. Thromb. Vasc. Biol. 17:1997;2744-2752.
10. Vinson J.A., Teufel K., Wu N. Red wine, dealcoholized red wine, and especially grape juice inhibit atherosclerosis in a hamster model. Atherosclerosis. 156:2001;67-72.
11. Burns J., Gardner P.T., O'Neil J., Crawford S., Morecroft I., McPhail D.B., Lister C., Matthews D., MacLean M.R., Lean M.E., Duthie G.G., Crozier A. Relationship among antioxidant activity, vasodilation capacity, and phenolic content of red wines. J. Agric. Food Chem. 48:2000;220-230.
12. Wadsworth T.L., Koop D.R. Effects of the wine polyphenolics quercetin and resveratrol on pro-inflammatory cytokine expression in RAW 264.7 macrophages. Biochem. Pharmacol. 57:1999;941-949.
13. Reanud S., de Lorgeril M. Wine alcohol, platelets and the French paradox from coronary heart disease. Lancet. 339:1992;1523-1526.
14. Shigematsu S., Ishida S., Hara M., Takahashi N., Yoshimatsu H., Sakata T., Korthuis R.J. Resveratrol, a red wine constituent polyphenol, prevents superoxide-dependent inflammatory responses induced by ischemia/reperfusion, platelet-activating factor, or oxidants. Free Radic. Biol. Med. 34:2003;810-817.
15. Karlsson J., Emgard M., Brundin P., Burkitt M.J. trans-Resveratrol protects embryonic mesencephalic cells from tert-butyl hydroperoxide: electron paramagnetic resonance spin trapping evidence for a radical scavenging mechanism. J. Neurochem. 75:2000;141-150.
16. Rotondo S., Rajtar G., Manarini S., Celardo A., Rotilio D., de Gaetano G., Evangelista V., Cerletti C. Effect of trans-resveratrol, a natural polyphenolic compound on human polymorphonuclear leukocyte function. Br. J. Pharmacol. 123:1998;1691-1699.
17. Ferrero M.E., Bertelli A.E., Fulgenzi A., Pellegatta F., Corsi M.M., Bonafrate M., Ferrara F., De Caterina R., Giovannini L., Bertelli A. Activity in vitro of resveratrol on granulocyte and monocyte adhesion to endothelium. Am. J. Clin. Nutr. 68:1998;1208-1214.
18. ′ -5-trihydroxystilbene) modulates granulocyte and monocyte endothelial adhesion Transplant. Proc. 30:1998;4191-4193.
19. Bhat K.P., Pezzuto J.M. Cancer chemopreventive activity of resveratrol. Ann. N. Y. Acad. Sci. 957:2002;210-229.
20. Kong A.N., Yu R., Hebbar V., Chen C., Owuor E., Hu R., Ee R., Mandlekar S. Signal transduction events elicited by cancer prevention compounds. Mutat. Res. 480/481:2001;231-241.
21. Subbaramaiah K., Dannenberg A.J. Resveratrol inhibits the expression of cyclooxygenase-2 in mammary epithelial cells. Adv. Exp. Med. Biol. 492:2001;147-157.
22. Korolkiewicz R.P., Ujda M., Dabkowski J., Ruczynski J., Rekowski P., Petrusewicz J. Differential salutary effects of nonselective and selective COX-2 inhibitors in postoperative ileus in rats. J. Surg. Res. 109:2003;161-169.
23. Brzozowski T., Konturek P.C., Konturek S.J., Sliwowski Z., Pajdo R., Drozdowicz D., Ptak A., Hahn E.G. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers. Microsc. Res. Tech. 53:2001;343-353.
24. Weber C., Erl W., Piettsc A., Strobel M., Ziegler-Heirbrock H.W., Weber P.C. Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-kappa B mobilization and induction of vascular cell adhesion molecule-1 in endothelial cells stimulated to generate radicals. Arterioscler. Thromb. Vasc. Biol. 14:1994;1665-1673.
25. Salah N., Miller N.J., Paganga G., Tijburg L., Bolwell G.P., Rice-Evans C. Polyphenolic flavanols as scavengers of aqueous phase radicals and as chain-breaking antioxidants. Arch. Biochem. Biophys. 322:1995;339-346.
26. Wiseman H., Halliwell B. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. J. Biochem. 313:1996;17-29.
27. Kehrer J.P. Free radicals as mediators of tissue injury and disease. Crit. Rev. Biochem. Mol. Biol. 23:1993;21-48.
28. Vallyathan V., Shi X. The role of oxygen free radicals in occupational and environmental lung diseases. Environ. Health Perspect. 105:1997;165-177.
29. Pietraforte D., Turco L., Azzini E., Minetti M. On-line EPR study of free radicals induced by peroxidase/H(2)O(2) in human low-density lipoprotein. Biochim. Biophys. Acta. 1583:2002;176-184.
30. Aust S.D., Chignell C.F., Bray T.M., Kalyanaraman B., Mason R.P. Free radicals in toxicology. Toxicol. Appl. Pharmacol. 120:1993;168-178.
31. Stohs S.J. The role of free radicals in toxicity and disease. J. Basic Clin. Physiol. Pharmacol. 6:1995;205-228.
32. Farber E. Cancer development and its natural history. A cancer prevention perspective. Cancer. 62(Suppl. 8):1988;1676-1679.
33. Langard S. One hundred years of chromium and cancer: a review of epidemiological evidence and selected case reports. Am. J. Ind. Med. 17:1990;189-215.
34. Halliwell B., Gutteridge J.M.C. Oxidative Stress. Free Radicals in Biology and Medicine. third ed. 2000;Oxford University Press, New York.
35. Huang C., Li J., Ding M., Wang L., Shi X., Castranova V., Vallyathan V., Ju G., Costa M. Arsenic-induced NFkappaB transactivation through Erks- and JNKs-dependent pathways in mouse epidermal JB6 cells. Mol. Cell. Biochem. 222:2001;29-34.
36. Janzen E.G., Balckburn B.J. Detection and identification of short-lived free radicals by an electron spin resonance trapping technique. J. Am. Chem. Soc. 90:1968;5909-5910.
37. Brambilla G., Martelli A., Marinari U.M. Is lipid peroxidation associated with DNA damage? Mutat. Res. 214:1989;123-127.
38. Daniel L.N., Mao Y., Saffiotti U. Oxidative DNA damage by crystalline silica. Free Radic. Biol. Med. 14:1993;463-472.
39. Shi X., Ding M., Ye J., Wang S., Leonard S.S., Zang L., Castranova V., Vallyathan V., Chiu A., Dalal N.S., Liu K. Cr(IV) causes activation of nuclear transcrition factor NF-κB, DNA strand breaks and dG hydroxylation via free radical reactions. J. Inorg. Biochem. 20:1999;663-668.
40. Buettner G.R. Spin trapping: ESR parameters of spin adducts. Free Radic. Biol. Med. 3:1987;259-303.
41. Shi X., Dalal N.S. Chromium(V) and hydroxyl radical generation during the glutathione reductase-catalyzed reduction of chromium(VI). Biochem. Biophys. Res. Commun. 163:1989;627-634.
42. Shi X., Ye J., Leonard S.S., Ding M., Vallyathan V., Castranova V., Rojanasakul Y., Dong Z. Antioxidant properties of (-)-epicatechin-3-gallate and its inhibition of Cr(VI)-induced DNA damage and Cr(IV)- or TPA-stimulated NF-kappaB activation. Mol. Cell. Biochem. 206:2000;125-132.
43. Finkelstein E., Rosen G.M., Rauckman E.J. Spin trapping of superoxide and hydroxyl radical: practical aspects. Arch. Biochem. Biophys. 200:1980;1-16.
44. Shi X., Dalal N.S. On the hydroxyl radical formation in the reaction between hydrogen peroxide and biologically generated chromium(V) species. Arch. Biochem. Biophys. 277:1990;342-350.
45. ·OH radical in the reduction of Cr(VI) in cellular media Arch. Biochem. Biophys. 281:1990;90-95.
46. Shi X., Mao Y., Knapton A., Ding M., Rojanasakul Y., Gannett P.M., Dalal N.S., Liu K. Reaction of Cr(VI) with ascorbate and hydrogen peroxide generates hydroxyl radicals and causes DNA damage: role of a Cr(IV)-mediated Fenton-like reaction. Carcinogenesis. 15:1994;2475-2478.
47. Shi X., Dalal N.S., Hu X., Vallyathan V. The chemical properties of silica particle surface in relation to silica-cell interactions. J. Toxicol. Environ. Health. 27:1989;435-454.
48. Leonard S.S., Wang S., Shi X., Jordan B.S., Castranova V., Dubick M.A. Wood smoke particles generate free radicals and cause lipid peroxidation, DNA damage, NFκB activation and TNF-α release in macrophages. Toxicology. 150:2000;147-157.
49. Yang C.S., Chung J.Y., Yang G., Chhabra S.K., Lee M.J. Tea and tea polyphenols in cancer prevention. J. Nutr. 130(Suppl. 2S):2000;472S-478S.
50. Leonard S., Wang S., Zang L., Castranova V., Vallyathan V., Shi X. Role of molecular oxygen in the generation of hydroxyl and superoxide anion radicals during enzymatic Cr(VI) reduction and its implication to Cr(VI)-induced carcinogenesis. J. Environ. Pathol. Toxicol. Oncol. 19:2000;49-60.
51. Chen F., Ding M., Lu Y., Leonard S.S., Vallyathan V., Castranova V., Shi X. Participation of MAP kinase p38 and IkappaB kinase in chromium(VI)-induced NF-kappaB and AP-1 activation. J. Environ. Pathol. Toxicol. Oncol. 19:2000;231-238.
52. Ye J., Zhang X., Young H.A., Mao Y., Shi X. Chromium(VI)-induced nuclear factor-kappa B activation in intact cells via free radical reactions. Carcinogenesis. 16:1995;2401-2405.
53. Shumilla J.A., Broderick R.J., Wang Y., Barchowsky A. Chromium(VI) inhibits the transcriptional activity of nuclear factor-kappaB by decreasing the interaction of p65 with cAMP-responsive element-binding protein-binding protein. J. Biol. Chem. 274:1999;36207-36212.
54. Shi X., Chiu A., Chen C.T., Halliwell B., Castranova V., Vallyathan V. Reduction of chromium(VI) and its relationship to carcinogenesis. J. Toxicol. Environ. Health. 2:1999;101-118.
55. Vaca C.E., Wilhelm J., Harms-Ringdahl M. Interaction of lipid peroxidation products with DNA. A review. Mutat. Res. 195:1988;137-149.
56. Esterbauer H. McBrien D.C.H., Slater T.F. Free Radicals, Lipid Peroxidation and Cancer. 1982;101-128 Academic Press, New York.
57. ·OH generation. An update FEBS Lett. 307:1992;108.
58. 4 and related DNA damage. Mol. Cell. Biochem. 234/235:2002;309-315.